ascendis pharma glp-1 receptor agonist weight management diabetes treatments Novo inks deal to develop long-acting GLP-1, other metabolic drugs GLP1 Receptor Agonists—Effects beyond Obesity
Description
18 During a period of rapid weight loss, hepatic cholesterol synthesis and secretion increase, which alters the ratio of cholesterol to bile salts within the gallbladder

Interestingly, many patients taking drugs such as Ozempic and Zepbound have reported similar experiences, saying their cravings for alcohol, cigarettes, or other substances decreased after starting treatment

16(9): e68390

A focused gastrointestinal review should ask about nausea, vomiting, abdominal distension, reflux, early satiety, constipation, postprandial fullness, and prior gastroparesis

Immunoglobulin Fc heterodimer platform technology: from design to applications in therapeutic antibodies and proteins

Cell Metab 17, 819837 (2013)
